Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06669494Enrolling by invitation
Study on ICU muscle weakness detection and monitoring
This study aims to find better ways to detect and track muscle weakness that can happen during an ICU stay. If you or your loved one is in the ICU, this research could help improve early diagnosis and care.
Seoul, SeoulAges 18 years+ - NCT07261735Recruiting
Custom attachments for clear aligner therapy
This study tests whether custom-made attachment composites improve the effectiveness of clear aligners for treating mild-to-moderate crowding or spacing. It may help you achieve better tooth movement during orthodontic treatment.
AnkaraAges Any age - NCT05400317RecruitingPhase 3
Check AD-218 for fibromyalgia symptoms and safety
This phase 3 study tests whether AD-218 works and is safe for people with fibromyalgia. It may help by improving symptoms, but it also carefully monitors side effects.
Daegu, Nam-guAges 19 years+ - NCT06582693Recruiting
Tobacco treatment for families through children's hospital
This study offers proactive, personalized help to stop smoking for adults who smoke and have a child who is a patient at Children's Hospital of Philadelphia. It aims to see if this approach works better than usual care.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06824285Recruiting
Brain wave markers in healthy aging
This study looks at how brain wave patterns change as people age normally, without any brain diseases. It may help researchers understand healthy aging better.
Rome, RomeAges 18 years+ - NCT07010354Recruiting
BeFlow Stent Study for Iliac Artery Blockages
This study is testing a new stent called BeFlow to see how well it works and how safe it is for people with blocked or narrowed iliac arteries. The stent is placed permanently to keep the artery open.
AalstAges 18 years+ - NCT06924606RecruitingPhase 2
Testing JS207 for advanced lung cancer after prior treatments
This trial tests a new drug called JS207 for people with advanced non-small cell lung cancer (NSCLC) that has gotten worse after standard treatments like chemotherapy and immunotherapy. It aims to see if JS207 can help shrink tumors or slow the cancer's growth.
Beijing, Beijing MunicipalityAges 18–75 - NCT06580080Recruiting
Testing the "Are You Ready?" program for teens
This trial tests a program called "Are You Ready?" designed to help teens and young adults who are involved with the juvenile justice or child welfare systems make informed decisions about their sexual health. It aims to see if the program works.
New Orleans, LouisianaAges 14–22 - NCT07255261Recruiting
Study of facial fillers for wrinkles and volume loss
This study tests several hyaluronic acid fillers to improve the look of hollows under the eyes, lips, lines around the mouth, smile lines, and cheeks. It is designed to see how well these fillers work in everyday use.
ArrasAges 18 years+ - NCT06375564RecruitingPhase 1
A new radioactive drug for advanced solid tumors
This trial tests a new radioactive drug (177Lu-AB-3PRGD2) that targets a protein called integrin αvβ3 found on many solid tumors. It is for people whose cancer has not responded to or has come back after several standard treatments.
Xiamen, FujianAges 18–90 - NCT07560371Enrolling by invitation
Testing a Mindfulness Refresher Course for NHS Staff
This study tests whether a short mindfulness "booster" course helps healthcare workers who've already done mindfulness training stay calm and reduce stress. You'd attend a few sessions to refresh your practice.
Worthing, West SussexAges 18 years+ - NCT07253259RecruitingEarly Phase 1
Cell therapy for hard-to-treat chronic graft-versus-host disease
This study tests a new cell therapy called GT729 for people with chronic graft-versus-host disease (cGVHD) that hasn't improved with at least two previous treatments. The therapy is given as an injection and aims to help control the immune system reaction that causes cGVHD.
Tianjin, Tianjin MunicipalityAges 18–65 - NCT07215390RecruitingPhase 2
Study of APL-3007 plus Syfovre for geographic atrophy
This trial tests whether a new drug called APL-3007, when added to your current Syfovre treatment, can slow the progression of geographic atrophy (an advanced form of dry age-related macular degeneration). It's for people who have already been on Syfovre for at least 6 months.
Gilbert, ArizonaAges 60 years+ - NCT07601412Recruiting
Understanding Immune Response to Respiratory Viruses in Older Adults
This study examines how the body's natural defense system (specifically a type of immune protein) responds to common respiratory viruses like flu and cold in older adults. Researchers will analyze nasal samples that are already being collected as part of routine care to better understand why older people sometimes have different immune responses to these infections.
LyonAges 60 years+ - NCT07326813RecruitingPhase 3
Testing D-2570 for moderate to severe plaque psoriasis
This trial tests if a new oral medication called D-2570 can safely and effectively treat moderate to severe plaque psoriasis. It may be an option if your psoriasis covers a large area and has been stable for at least 6 months.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06826898Recruiting
Hydrogel to prevent scar tissue after ankle ligament repair
This trial tests a special gel placed during ankle ligament repair surgery to see if it prevents painful scar tissue from forming. It might help people with chronic ankle sprains who need surgery.
ChanghuaAges 18–60 - NCT06544837Recruiting
Testing a new non-invasive test for women with implantation failure
This trial is testing a new, non-invasive test (called Ora) that checks when your uterine lining is ready for an embryo. It is for women who have had a failed transfer with a genetically normal embryo and are planning a frozen embryo transfer.
HanoiAges 28–45 - NCT07245862Recruiting
Family program for screen use conflicts
This study is for families who are dealing with conflicts about video games or screen use. It tests a program designed to help families work together and find a healthier balance.
LundAges 11–14 - NCT06523868Recruiting
Multi-cancer early detection test for military veterans
This trial is testing a blood test that looks for early signs of multiple types of cancer. It is designed for current or former military members who are at least 45 years old and have used VA healthcare. If the test finds something, you would need to be willing to travel to Boston for follow-up.
Boston, MassachusettsAges 45 years+ - NCT06270056Recruiting
Telemedicine abortion service study in Ecuador
This study tests using telemedicine (phone or video visits) to provide medication abortion pills to women in Ecuador. It aims to see if this approach is safe and effective for early pregnancy (up to 12 weeks), making abortion care more accessible.
AmbatoAges 15 years+ - NCT06830798RecruitingPhase 3
Ravulizumab to prevent delayed graft function after kidney transplant
This study tests an investigational medicine (ravulizumab) given through a vein to see if it can prevent delayed graft function—meaning the new kidney takes longer to start working—after a high-risk kidney transplant. It is for adults on dialysis who are getting a kidney from a donor whose heart stopped or who is considered high-risk.
Phoenix, ArizonaAges 18 years+ - NCT07234890RecruitingPhase 2
Testing AV-001 to protect the brain during hemodialysis
This study tests a new medicine called AV-001 to see if it can protect the brain from damage caused by hemodialysis. If you qualify, you may help find a way to reduce thinking and memory problems linked to dialysis.
London, OntarioAges 18 years+ - NCT07234617Recruiting
Green Prescription Program Study for Pregnant Women
This study looks at the Green Prescription program, which is a special health program for pregnant women. The goal is to see how well it works for women who are less than 32 weeks pregnant and speak French.
StrasbourgAges 18 years+ - NCT07234591Recruiting
Study of an oral medication for moderate to severe plaque psoriasis
This study tests an experimental oral medication (a TYK2 inhibitor) for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing psoriasis symptoms.
ShanghaiAges 18–70
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.